| | 
Part, Chapter, Paragraph
1 II, 5. 5. 3| inequalities in terms of waiting lists for diagnosis, in
2 II, 5. 7. 5| all citizens. The average waiting time for transplantation
3 II, 5. 11. 3| mild ailments which ill the waiting rooms and may not be so
4 II, 9. 2. 3| service provision and long waiting lists for child psychiatry
5 II, 9. 3. 3| sexual-health services, reduced waiting times in genitourinary clinics,
6 IV, 11. 1. 2| as sources of financing, waiting times, provider payment
7 IV, 11. 1. 3| accessing care, such as long waiting lists; a lack of incentives
8 IV, 11. 1. 3| such as infant mortality, waiting lists or other specific
9 IV, 11. 1. 4| Organizational factors such as waiting times, and geographical
10 IV, 11. 1. 4| cross-national OECD project on waiting times identifies European
11 IV, 11. 1. 4| countries with significant waiting times problems as: Denmark,
12 IV, 11. 1. 4| and Hurst, 2004). While waiting times represent a significant
13 IV, 11. 1. 4| differential experiences of waiting times across population
14 IV, 11. 1. 5| cervical cancer screening, waiting time for femur fracture
15 IV, 11. 1. 6| include survival rates, waiting times, patient experiences
16 IV, 11. 1. 6| patients experienced lower waiting times and increased accessibility,
17 IV, 11. 2. 1| activity, efficiency and reduce waiting times; although some variation
18 IV, 11. 5. 4| 000 patients are now on waiting lists in Europe. About 10
19 IV, 11. 5. 4| Europe. About 10 people waiting for an organ donation die
20 IV, 11. 5. 4| donation die everyday in Europe waiting for a transplant. Mortality
21 IV, 11. 5. 4| transplant. Mortality rates while waiting for a heart, liver or lung
22 IV, 11. 5. 4| patients and time spent on waiting lists. Demand for transplants
23 IV, 11. 5. 4| transplants and length of waiting lists.~Collaboration at
24 IV, 11. 5. 6| management of organ transplant waiting lists and waiting times ~
25 IV, 11. 5. 6| transplant waiting lists and waiting times ~2001Recom )4 on the
26 IV, 11. 5. 6| criteria for the management of waiting lists and waiting times
27 IV, 11. 5. 6| management of waiting lists and waiting times in health care (adopted
28 IV, 11. 6. 4| measurements of survival or waiting time (e.g. in case of hip
29 IV, 11. 6. 5| Hurst J (2004): Explaining waiting time variations for elective
30 IV, 12. 1 | Portugal, and currently waiting for ratification. Only minor
31 IV, 12. 4 | hospital performances (waiting time and nosocomial diseases);
32 IV, 12. 10 | for patients who are on waiting lists at hospitals beyond
33 IV, 13. 5 | hospital performances (waiting time and nosocomial diseases);
|
|
| |
